Combined Systemic Immunotherapy and Intrathecal Dexamethasone in Febrile Infection Related Epilepsy Syndrome
Annals of Clinical and Translational Neurology · 2025-04 · 12 (4) · 871-875
DOI: 10.1002/acn3.70011 ↗Kurz gefasst
Fallbericht in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 11.02.2025. Verfasst von Kristen S Fisher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Te…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Dexamethasone, Immunotherapy, Interleukin 1 Receptor Antagonist Protein. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Febrile infection related epilepsy syndrome (FIRES) is a rare presentation of refractory status epilepticus with immune dysregulation as a potential pathologic mechanism. Despite promising results from second‐line immunomodulators, approximately 30% remain refractory to treatment. We describe two children with FIRES who were unable to wean from anesthetic infusions with immunomodulatory treatment and subsequently received concurrent intrathecal dexamethasone and anakinra/tocilizumab as escalation of therapy. Following the initiation of this combined regimen, anesthetic infusions were decreased while maintaining seizure freedom. These cases demonstrate proof of principle that a multi‐modal approach may be beneficial and should be considered in the treatment of FIRES.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
- Department of Pharmacy, Texas Children's Hospital, Houston, Texas, USA.
- Division of Rheumatology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
- Division of Pediatric Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine at Texas Children's Hospital, Houston, Texas, USA.
ORCID-Profile: Eyal Muscal, Yi-Chen Lai
Zitieren
APA
Fisher, K. S., Ankar, A., Cokley, J., Muscal, E., Riviello, J. J., & Lai, Y. C. (2025). Combined Systemic Immunotherapy and Intrathecal Dexamethasone in Febrile Infection Related Epilepsy Syndrome. Annals of Clinical and Translational Neurology, 12(4), 871-875. https://doi.org/10.1002/acn3.70011
Vancouver
Fisher KS, Ankar A, Cokley J, Muscal E, Riviello JJ, Lai YC. Combined Systemic Immunotherapy and Intrathecal Dexamethasone in Febrile Infection Related Epilepsy Syndrome. Annals of Clinical and Translational Neurology. 2025;12(4):871-875. doi:10.1002/acn3.70011
BibTeX
@article{Fisher2025,
author = {Fisher, Kristen S and Ankar, Alexander and Cokley, Jon and Muscal, Eyal and Riviello, James J and Lai, Yi-Chen},
title = {Combined Systemic Immunotherapy and Intrathecal Dexamethasone in Febrile Infection Related Epilepsy Syndrome},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
volume = {12},
number = {4},
pages = {871--875},
doi = {10.1002/acn3.70011}
}
EUVIMED